A5020496622- RNA Interference and Gene Delivery
- Immunotherapy and Immune Responses
- Nanoplatforms for cancer theranostics
- Immune cells in cancer
- Extracellular vesicles in disease
- Cancer Research and Treatments
- Immune Cell Function and Interaction
- CAR-T cell therapy research
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Pluripotent Stem Cells Research
- Advanced Nanomaterials in Catalysis
- CRISPR and Genetic Engineering
- Hematopoietic Stem Cell Transplantation
- Cancer, Hypoxia, and Metabolism
- Advanced biosensing and bioanalysis techniques
- Phagocytosis and Immune Regulation
China Pharmaceutical University
2021-2024
State Key Laboratory of Natural Medicine
2021-2024
Dilated erythrocyte membrane specifically transfer iPSC to spleen for effective tumor prevention.
As an efficient tumor immunotherapy, PD-1 antibody has been gradually used in clinical treatment, but the low response rate and excessive immune limit its extensive application.Herein, a therapeutic regime for reinvigoration activation of microenvironment is introduced to improve anti-tumor effect antibody. To comprehensively immunotherapy reduce response, biomimetic cascade targeting nanosystem, siRNA@PLOV, which was fused by photothermal sensitive liposomes (PTSLs) attenuated Salmonella...
<div>Abstract<p>Cancer vaccines are an approach to elicit amplified antigen-specific immune responses. Induced pluripotent stem cells (iPSC) have potential utility for the development of universal because their intrinsic antigenic epitopes. Concurrently, iPSCs can undergo differentiation and thus a stable source both antigen-presenting producing cell-based tumor organoids facilitating exploration adaptive assessment vaccines. This review describes specific contributions vaccine...
<p>Supplemental Material of CAN-24-0642-AT</p>